Zdrowie i gospodarka · 10/09/2015

FDA Publishes Guidance on Elemental Impurities for Pharmaceuticals

The FDA has released a guidance on elemental impurities in pharmaceuticals, developed under the International Conference on Harmonisation, to establish daily exposure limits for 24 elements and provide a risk-based approach to assessing their presence in products.